disinfozone/The_Info_Web
1
0
Fork 0
Code Issues Pull requests Projects Releases Packages Wiki Activity Actions

vault backup: 2026-10-03 20:19:03

Browse source
This commit is contained in:
disinfo.zone 2026-10-03 20:19:03 -04:00
parent 3d178b0887
commit f382799352
No known key found for this signature in database
53 changed files with 2511 additions and 430 deletions
Download patch file Download diff file Expand all files Collapse all files

88
10 - PEOPLE/(N-S)/Garry Nolan.md
View file

@ -5,7 +5,62 @@ category: "UFO & Anomalous Phenomena"
tags:
- Person
- UFO
- Stanford
- SolFoundation
- Akoya
alias:
- Garry Nolan
- Garry P. Nolan
- Garry Nolan, Ph.D.
- Dr. Garry Nolan
summary: "Garry Nolan is a leading research scientist at Stanford University, specializing in genetics, immunology, and bioinformatics."
relations:
relations:
- type: employed_by
with: "[[Stanford University]]"
role: "Rachford and Carlota A. Harris Professor, Department of Pathology, School of Medicine"
fn: 13
- type: director_of
with: "[[Nodality]]"
start: 2009-10-19
role: "executive officer and director on the Form D signed October 26, 2009 (offering $10,000,000, $3,499,999 sold) and director on the Form D signed January 12, 2010 (offering $13,500,000, $9,999,997 sold)"
fn: 3
- type: director_of
with: "[[DVS Sciences]]"
start: 2010-12-20
role: "director on Form D filed February 16, 2011 (offering $14,797,741; $4,131,828 sold, six investors)"
fn: 4
- type: director_of
with: "[[BINA Technologies]]"
start: 2011-04-08
role: "director on Forms D filed April 21, 2011 ($1,500,000 offered, $1,100,000 sold, nine investors) and March 28, 2012 ($2,000,000 offered, $1,204,545 sold, twelve investors)"
fn: 5
- type: director_of
with: "[[PrognosDx Health]]"
start: 2011-02-28
role: "director on Forms D filed March 15, May 17 and June 28, 2011"
fn: 6
- type: founded
with: "[[Akoya Biosciences]]"
role: "co-founder and director (director on Forms D of July 2017 and October 2018; Form 3 filed April 20, 2021 as director holding 680,084 common shares); company acquired by Quanterix in 2025"
fn: 7
- type: member_of
with: "[[To The Stars Academy of Arts & Science]]"
start: 2017-08-15
role: "named to the advisory board in the Regulation A offering circular of August 15, 2017, with Christopher Mellon, Adele Gilpin, Norman Kahn, Colm Kelleher and Paul Rapp"
fn: 8
- type: founded
with: "[[Sol Foundation]]"
start: 2023-08-15
role: "co-founder; director (0 hours, no compensation) on the 2024 Form 990"
fn: 9
- type: member_of
with: "[[UAP Science Advisory Council]]"
start: 2026-06
role: "materials science and molecular biology, on the list Avi Loeb supplied to DefenseScoop"
fn: 15
updated: 2026-10-03
created: 2026-10-03
---
Garry Nolan is a leading research scientist at [[Stanford University]], specializing in genetics, immunology, and bioinformatics. He trained under Nobel Prize-winning biologist [[David Baltimore]] and has published over 200 research papers and holds twenty biotechnology patents[^1].
@ -29,6 +84,39 @@ Further research revealed that many of the individuals in the study group had be
Dr. Nolan has also been involved in the analysis of alleged UAP materials. He and the French scientist [[Jacques Vallee]] collaborated on a paper analyzing a metallic slag recovered from a 1977 UAP crash in Council Bluffs, Iowa. Their analysis revealed that the material contained isotopes of magnesium and iron that were arranged in a highly structured and deliberate manner, a feat that is beyond our current technological capabilities.[^2]
### Companies and investors
Securities filings name Nolan as a director or executive officer of a series of private life-science companies. On Form D filings with the [[Securities and Exchange Commission]] he appears as an executive officer and director of [[Nodality]] (first filing, signed October 26, 2009, for a $10,000,000 offering of which $3,499,999 had been sold to one investor) and as a director of the same company on the second filing (January 2010, a $13,500,000 offering of which $9,999,997 had been sold to four investors), as a director of [[DVS Sciences]] (filed February 16, 2011, $14,797,741 offered, $4,131,828 sold), as a director of [[BINA Technologies]] (filed April 21, 2011 and March 28, 2012, the second recording $1,204,545 sold to twelve investors) and as a director of [[PrognosDx Health]] (three filings between March and June 2011, for $25,000, $10,000 and $15,000, each sold to one investor).[^3][^4][^5][^6]
[[Akoya Biosciences]] filed Forms D on July 14, 2017 (nine million dollars offered and sold, six investors) and October 2, 2018 ($25,500,000 offered, $24,500,000 sold), each listing Nolan with [[Thomas Raffin]], [[Robert Shepler]] and [[Matthew Winkler]] as directors. Its 2021 prospectus calls Nolan "our co-founder and director," says he "originally developed our CODEX technology" at Stanford, which licenses the patents to the company, and says he is the first recipient of the [[Teal Innovator Award]] (2012) from the [[Department of Defense]]. Raffin is described there as a co-founder of [[Rigel Pharmaceuticals]] and of the [[San Francisco]] life-science private equity firm [[Telegraph Hill Partners]]. Nolan filed a Form 3 on April 20, 2021 as a director holding 680,084 shares of common stock and options on 42,918 more.[^7] Akoya's proxy statements for 2022, 2023 and 2024 and its 2025 merger proxy with [[Quanterix]] carry his name.[^7]
### Advisory boards
The Regulation A offering circular of [[To The Stars Academy of Arts & Science]] filed with the Securities and Exchange Commission on August 15, 2017 lists an advisory board of [[Christopher Mellon]], [[Adele Gilpin]], [[Norman Kahn]], [[Colm Kelleher]], Nolan and [[Paul Rapp]], gives Nolan's chair as the Rachford and Carlota A. Harris Professorship in the Department of Microbiology and Immunology (the November 2024 letter to Congress gives the Department of Pathology), and describes Nolan as "the founder" of "several successful biotechnology companies" who "is an outspoken proponent of translating public investment in basic research to serve the public welfare."[^8]
### Sol Foundation and later activity
Nolan co-founded the [[Sol Foundation]] with [[Peter Skafish]] and was introduced in 2023 as its "Executive Director of the Board." He said that because of his Stanford position he could not hold an officer role in an outside company and took no salary.[^9] The foundation's 2024 Form 990 lists him as a director at zero hours and zero compensation, and the [[Internal Revenue Service|IRS]] master file gives his Redwood City address as the care-of address for the organization's records.[^9][^10] The foundation's website, read October 3, 2026, lists him as "Co-Founder & Executive Director of the Board."[^11] The November 2023 symposium was hosted by the Nolan Laboratory and the Stanford School of Medicine.[^12] He signed the November 12, 2024 letter to Congress urging passage of the review-board provisions of the [[Unidentified Anomalous Phenomena Disclosure Act]], listing his chair as the Rachford and Carlota A. Harris Professorship in Pathology.[^13]
In Encounters (2023), [[Diana Walsh Pasulka]] identified the figure she had called "James Master" in American Cosmic, a "world leading scientist" who had analyzed an alleged artifact, as Nolan.[^14] In June 2026 Nolan, Skafish and [[Tim Gallaudet]] were named among twelve members of a UAP Science Advisory Council led by [[Avi Loeb]].[^15]
The [[Federal Election Commission]] database lists contributions from a Garry Nolan of Redwood City, California who gives Stanford as his employer: $250 to [[Hillary Clinton]]'s 2016 campaign committee on April 7, 2016, $2,900 to [[Mike Levin]]'s congressional campaign on March 22, 2021, and small amounts through [[ActBlue]] to other Democratic candidates, most recently on October 28, 2024.[^16]
### Footnotes
[^1]: Jacobsen, Annie. *Phenomena: The Secret History of the U.S. Government's Investigations into Extrasensory Perception and Psychokinesis*. Little, Brown and Company, 2017.
[^2]: Elizondo, Luis. *Imminent*. William Morrow, 2024.
[^3]: SEC Form D, Nodality Inc, accession 0001372142-09-000007 (filed October 26, 2009; first sale October 19, 2009) and 0001372142-10-000001 (filed January 13, 2010; first sale December 30, 2009). https://www.sec.gov/Archives/edgar/data/1372142/000137214209000007/primary_doc.xml
[^4]: SEC Form D, DVS Sciences, Inc., accession 0001512982-11-000001, filed February 16, 2011. https://www.sec.gov/Archives/edgar/data/1512982/000151298211000001/primary_doc.xml
[^5]: SEC Form D, BINA Technologies Inc., accessions 0001518373-11-000002 (filed April 21, 2011) and 0001518373-12-000003 (filed March 28, 2012). https://www.sec.gov/Archives/edgar/data/1518373/000151837312000003/primary_doc.xml
[^6]: SEC Form D, PrognosDx Health, Inc., accessions 0001515122-11-000002, -000003 and -000004 (filed March 15, May 17 and June 28, 2011). https://www.sec.gov/Archives/edgar/data/1515122/000151512211000002/primary_doc.xml
[^7]: SEC Form D, Akoya Biosciences, Inc. (CIK 1711933), accessions 0001446933-17-000008 (first sale July 12, 2017, signed July 14, 2017) and 0001446933-18-000007 (first sale September 26, 2018, signed October 2, 2018), https://www.sec.gov/Archives/edgar/data/1711933/000144693317000008/primary_doc.xml ; Form 3, Garry Nolan, accession 0001104659-21-052709 (April 20, 2021); prospectus (424B4), accession 0001104659-21-051518 (April 19, 2021), "Management" and "Business" sections. https://www.sec.gov/Archives/edgar/data/1711933/000110465921051518/tm212065-15_424b4.htm
[^8]: To The Stars Academy of Arts & Science Inc., Form 1-A, offering circular Part II and III, accession 0001144204-17-043466 (filed August 15, 2017), "Advisory Board." https://www.sec.gov/Archives/edgar/data/1710274/000114420417043466/v473169_partiiandiii.htm
[^9]: Micah Hanks, "The Sol Foundation: How a New Think Tank of Academics is Applying 'Cutting-Edge Research' to the UAP Mystery," *The Debrief*, September 12, 2023. https://thedebrief.org/the-sol-foundation-how-a-new-think-tank-of-academics-is-applying-cutting-edge-research-the-uap-mystery/
[^10]: IRS Form 990 for 2024, EIN 93-3649160; ProPublica Nonprofit Explorer API record for the same EIN. https://projects.propublica.org/nonprofits/organizations/933649160
[^11]: The Sol Foundation, home page, "People" section, https://thesolfoundation.org/ , read October 3, 2026.
[^12]: Micah Hanks, *The Debrief*, February 12, 2024. https://thedebrief.org/the-sol-foundation-academias-new-uap-think-tank-releases-videos-of-lectures-from-its-inaugural-symposium/
[^13]: Signatory entry in the letter of November 12, 2024, statement of Tim Gallaudet, House Committee on Oversight and Accountability, hearing of November 13, 2024. https://docs.house.gov/meetings/GO/GO12/20241113/117721/HHRG-118-GO12-Wstate-GallaudetPhDRearAdmiralUSNavyRetT-20241113-SD001.pdf
[^14]: Nathaniel Rich, "Ufologists, Unite!," *The New York Review of Books*, April 18, 2024 (sole source for the passage so cited; Encounters not opened). https://www.nybooks.com/articles/2024/04/18/ufologists-unite-american-cosmic-d-w-pasulka/
[^15]: "New science advisory council forms to help US government 'resolve the UAP mystery,'" *DefenseScoop*, June 17, 2026. https://defensescoop.com/2026/06/17/new-science-advisory-council-forms-to-help-us-government-resolve-the-uap-mystery/
[^16]: Federal Election Commission, Schedule A receipts, contributor name "NOLAN, GARRY," city Redwood City, queried October 3, 2026 (twenty-five records, 2016 to 2024; employer given as Stanford University or Stanford University School of Medicine). The identity of the donor with the Stanford professor rests on the employer field only.